Edition:
United Kingdom

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

58.86USD
12 Dec 2018
Change (% chg)

$0.37 (+0.63%)
Prev Close
$58.49
Open
$58.93
Day's High
$60.06
Day's Low
$58.81
Volume
269,607
Avg. Vol
332,794
52-wk High
$95.82
52-wk Low
$57.78

Chart for

About

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $12,381.50
Shares Outstanding(Mil.): 142.61
Dividend: 0.16
Yield (%): 0.74

Financials

  PRGO.N Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -20.55 -- --
ROI: -22.33 15.55 14.96
ROE: -38.96 16.92 16.52

AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge

A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.

30 Jun 2018

UPDATE 2-AbbVie, AndroGel partner owe $448 million in antitrust case -U.S. judge

June 29 A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.

30 Jun 2018

Earnings vs. Estimates